Cargando…
Dendritic Cells: The Long and Evolving Road towards Successful Targetability in Cancer
Dendritic cells (DCs) are a unique myeloid cell lineage that play a central role in the priming of the adaptive immune response. As such, they are an attractive target for immune oncology based therapeutic approaches. However, targeting these cells has proven challenging with many studies proving in...
Autores principales: | Marmonti, Enrica, Oliva-Ramirez, Jacqueline, Haymaker, Cara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563837/ https://www.ncbi.nlm.nih.gov/pubmed/36230990 http://dx.doi.org/10.3390/cells11193028 |
Ejemplares similares
-
Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End
por: Datsi, Angeliki, et al.
Publicado: (2021) -
Dendritic cells and natural killer cells: The road to a successful oncolytic virotherapy
por: Ghasemi, Matin, et al.
Publicado: (2023) -
China’s Belt and Road: An Evolving Network
por: Ali, S. Mahmud
Publicado: (2020) -
Differential Effects of Pancreatic Cancer-Derived Extracellular Vesicles Driving a Suppressive Environment
por: Purushothaman, Anurag, et al.
Publicado: (2023) -
A multifactorial anti‐cachectic approach for cancer cachexia in a rat model undergoing chemotherapy
por: Toledo, Míriam, et al.
Publicado: (2015)